Webush upgrades Snowflake, Elastic to Outperform on AI optimism

Investing.com
Updated
Mitrade
coverImg
Source: Shutterstock

Investing.com-- Wedbush upgraded its rating on software firms Snowflake and   Elastic  , citing increased optimism over their exposure to the rapidly growing artificial intelligence industry, especially on an enterprise level.

Webush upgraded both Snowflake Inc (NYSE:SNOW) and Elastic NV (NYSE:ESTC) to Outperform from Neutral. The brokerage also hiked its price targets on software majors Palantir Technologies Inc (NYSE:PLTR) and Salesforce Inc (NYSE:CRM).

For Snowflake, Wedbush said it expects to see “marked improvement” in product revenues before an AI-fueled 2026. The cloud firm is in a “sweet spot” to benefit from AI use cases in the next 12 to 18 months, Wedbush said.

For Elastic, Wedbush said the cloud firm was likely to benefit from increased demand for its platform approach to cloud computing, especially with more customers looking to pivot from legacy vendors. 

Cloud firms are expected to benefit from the rapidly growing computational requirements of AI programs, especially given that most AI users will be unwilling to set up their own AI server infrastructure. 

Both Snowflake and Elastic clocked strong earnings last week, driving their stock prices to multi-month highs. 

Wedbush hiked its price target on Palantir to $75 from $57, citing increased confidence in the firm’s AI as  a platform strategy, as well as exposure to increased use cases for AI. The stock is rated as Outperform.

For Salesforce, Wedbush hiked its price target to $375 from $325 and maintained the stock at Outperform. The brokerage said it saw increased demand for Salesforce’s offerings, especially on the AI front.

* The content presented above, whether from a third party or not, is considered as general advice only.  This article should not be construed as containing investment advice, investment recommendations, an offer of or solicitation for any transactions in financial instruments.

goTop
quote
Do you find this article useful?
Related Articles
placeholder
Could Buying Costco Today Set You Up for Life?Costco (NASDAQ: COST) is a store I frequent almost weekly, thanks to the good prices and the shockingly fresh produce. That said, I've never owned the stock, even though it has the type of impressive dividend record that attracts my attention.
Author  The Motley Fool
4 hours ago
Costco (NASDAQ: COST) is a store I frequent almost weekly, thanks to the good prices and the shockingly fresh produce. That said, I've never owned the stock, even though it has the type of impressive dividend record that attracts my attention.
placeholder
These Supercharged Tech Stocks Still Trade at Attractive ValuationsDemand for artificial intelligence (AI) is driving significant gains for leading chip stocks. These companies are playing pivotal roles in the adoption of this technology, and there are still opportunities for investors to make money.
Author  The Motley Fool
4 hours ago
Demand for artificial intelligence (AI) is driving significant gains for leading chip stocks. These companies are playing pivotal roles in the adoption of this technology, and there are still opportunities for investors to make money.
placeholder
Prediction: Nvidia Stock Is Going to Soar Over the Next 12 MonthsNvidia (NASDAQ: NVDA) is the world's leading supplier of graphics processing units (GPUs) for data centers, which are used in the development of artificial intelligence (AI). Over the last two years alone, GPU sales have helped Nvidia add $3.2 trillion to its valuation.
Author  The Motley Fool
Nov 22, Fri
Nvidia (NASDAQ: NVDA) is the world's leading supplier of graphics processing units (GPUs) for data centers, which are used in the development of artificial intelligence (AI). Over the last two years alone, GPU sales have helped Nvidia add $3.2 trillion to its valuation.
placeholder
Got $500? 1 Biotech Stock to Buy and Hold ForeverIf you have $500, you should check out Vertex Pharmaceuticals (NASDAQ: VRTX). Here's why this biotech stock is a great candidate to buy and hold forever.
Author  The Motley Fool
Nov 22, Fri
If you have $500, you should check out Vertex Pharmaceuticals (NASDAQ: VRTX). Here's why this biotech stock is a great candidate to buy and hold forever.
placeholder
Microsoft’s LinkedIn lays off 200 employees- The InformationInvesting.com-- LinkendIn laid off about 200 employees over the past two weeks, The Information reported on Thursday, with the cuts happening within the engineering and customer support departments.
Author  Investing.com
Nov 22, Fri
Investing.com-- LinkendIn laid off about 200 employees over the past two weeks, The Information reported on Thursday, with the cuts happening within the engineering and customer support departments.